Company News in the Life Science Industry

»

Reset 

Alopexx Vaccine Announces Licensing Agreement with Merck Animal Health

CONCORD, Mass., Jan. 14, 2019 /PRNewswire/ -- Alopexx Vaccine, LLC announced today that it has entered into an exclusive global license agreement with Merck Animal Health to develop and commercialize its poly-N-acetyl glucosamine (PNAG) vaccine for Rhodococcus equi (R. equi)... Read more ››

By: PR Newswire Association LLC. - 14 Jan 2019
Related companies:  Alopexx Vaccine LLC

Beth Landry Joins Caregiver, Inc., as President of Operations in Indiana, Tennessee and Ohio

FORT WORTH, Texas, Jan. 14, 2018 /PRNewswire/ -- Mark Lashley, President and CEO of Caregiver, Inc., a leading provider of services to adults with intellectual and developmental disabilities, has announced the appointment of Beth Landry as President of Operations for Caregiver's recently acquired... Read more ››

By: PR Newswire Association LLC. - 14 Jan 2019

Global Markets and Technologies for Nanofibers

NEW YORK, Jan. 14, 2019 /PRNewswire/ -- Report Scope:
This report provides an updated review of nanofiber technology, including materials and production processes, and identifies current and emerging applications for this technology.

Read the full report: Read more ››

By: PR Newswire Association LLC. - 14 Jan 2019

FDA Approves Expanded Use of Adacel® (Tdap) Vaccine for Repeat Vaccination

BRIDGEWATER, N.J., Jan. 14, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has approved the expanded use of Adacel(®) (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine Adsorbed) to include repeat vaccination to help protect against tetanus, diphtheria... Read more ››

By: PR Newswire Association LLC. - 14 Jan 2019

Global Portable Imaging Solutions Market: Focus on Product Type, End-Users, Competitive Landscape, 22 Countries Data - Analysis and Forecast, 2018-2028

NEW YORK, Jan. 14, 2019 /PRNewswire/ -- Global Portable Imaging Solutions Market is Expected to Reach $5.74 billion by 2028

Read the full report: Read more ››

By: PR Newswire Association LLC. - 14 Jan 2019

Array BioPharma Announces 15.3 Months Median Overall Survival from the Safety Lead-in of the Phase 3 BEACON CRC Trial of the Combination BRAFTOVI®, MEKTOVI® and ERBITUX® in BRAF-Mutant Metastatic Colorectal Cancer

BOULDER, Colo., Jan. 14, 2019 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced updated safety and efficacy results, including mature overall survival (OS), from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of BRAFTOVI(®) (encorafenib),... Read more ››

By: PR Newswire Association LLC. - 14 Jan 2019
Related companies:  ARRAY BIOPHARMA Inc.

Post-Hoc Analyses from Pivotal Phase 3 REFLECT Trial of LENVIMA® (lenvatinib) in Unresectable Hepatocellular Carcinoma to be Presented at 2019 Gastrointestinal Cancers Symposium

WOODCLIFF LAKE, N.J., Jan. 14, 2019 /PRNewswire/ -- Eisai Inc. announced today the presentation of four abstracts at the 2019 Gastrointestinal Cancers Symposium (#GI19), taking place in San Francisco from January 17-19, 2019. The presentations feature the latest data from post-hoc analyses of... Read more ››

By: PR Newswire Association LLC. - 14 Jan 2019
Related companies:  Eisai Inc.

An Innovative Approach to Pricing Drugs Can Accelerate the Eradication of Diseases

SAN FRANCISCO, Jan. 14, 2019 /PRNewswire/ -- Achieving the full societal benefits of curing chronic or life-threatening diseases will remain an elusive goal unless the pharmaceutical industry changes its economic model, according to new report by Read more ››

By: PR Newswire Association LLC. - 14 Jan 2019

Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

NASDAQ, TSX: NVCN

Read more ››
By: PR Newswire Association LLC. - 14 Jan 2019
Related companies:  NEOVASC INC.

Zomedica Announces $4.28 Million Private Placement Closing and Corporate Update

Read more ››
By: Nasdaq / GlobenewsWire - 14 Jan 2019

Ancient Nutrition Names Greg Shearson as CEO, Adding to Leadership Team of Founders Jordan Rubin and Dr. Josh Axe

Read more ››
By: Nasdaq / GlobenewsWire - 14 Jan 2019

Scilex Announces ZTlido® Insurance Coverage for ~100 Million Insured Lives(1)

Read more ››
By: Nasdaq / GlobenewsWire - 14 Jan 2019
Related companies:  Sorrento Therapeutics, Inc.

Scilex Announces Addition of ZTlido® to Express Scripts National Formularies

Read more ››
By: Nasdaq / GlobenewsWire - 14 Jan 2019
Related companies:  Sorrento Therapeutics, Inc.

Aleafia Fulfills First Transaction Under Cannabis Supply Agreement with CannTrust

Read more ››
By: Nasdaq / GlobenewsWire - 14 Jan 2019

Microbot Medical Increases its Global IP Portfolio with Notice of Allowance from the European Patent Office

Read more ››
By: Nasdaq / GlobenewsWire - 14 Jan 2019
Related companies:  Microbot Medical Inc. | Microbot Medical Ltd.

Nabriva Therapeutics Provides Update on PDUFA Date for Intravenous CONTEPO™

Read more ››
By: Nasdaq / GlobenewsWire - 14 Jan 2019
Related companies:  Nabriva Therapeutics plc

Nash Pharmaceuticals Announces Positive Pre-Clinical Results From a Second Study for Chronic Kidney Disease as well as 2 Additional Lead Targets

Read more ››
By: Nasdaq / GlobenewsWire - 14 Jan 2019

ReWalk Announces Preliminary Fiscal Year 2018 Revenue

Read more ››
By: Nasdaq / GlobenewsWire - 14 Jan 2019
Related companies:  ReWalk Robotics Ltd.

Canopy Rivers Targets CBD Health and Wellness Market With Investment in Greenhouse Juice Company

Read more ››
By: Nasdaq / GlobenewsWire - 14 Jan 2019

Award of Restricted Stock Units

Read more ››
By: Nasdaq / GlobenewsWire - 14 Jan 2019
Related companies:  Summit Therapeutics plc
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 23  24  25 »

Explore our database of over 50,000 companies